<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-cells-09-00720">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chabeda</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yanez</surname>
    <given-names>R.J.R.</given-names>
   </name>
   <name>
    <surname>Lamprecht</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Meyers</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Rybicki</surname>
    <given-names>E.P.</given-names>
   </name>
   <name>
    <surname>Hitzeroth</surname>
    <given-names>I.I.</given-names>
   </name>
  </person-group>
  <article-title>Therapeutic vaccines for high-risk HPV-Associated diseases</article-title>
  <source>Papillomavirus Res.</source>
  <year>2017</year>
  <volume>5</volume>
  <fpage>46</fpage>
  <lpage>58</lpage>
  <pub-id pub-id-type="doi">10.1016/j.pvr.2017.12.006</pub-id>
  <pub-id pub-id-type="pmid">29277575</pub-id>
 </element-citation>
</ref>
